Comparison between the Interferon γ Release Assay—QuantiFERON Gold Plus (QFT-Plus)—and Tuberculin Skin Test (TST) in the Detection of Tuberculosis Infection in Immunocompromised Ch... by Cory Primaturia, Lelani Reniarti, Heda M. N. Nataprawira

“…The total number of patients with positive QFT-Plus and TST results was 11/71 (15.5%) and 4/71 (5.6%), respectively, among whom 3/11 patients had positive results in both tests, and one patient with positive TST results exhibited a discrepancy, as this was not followed by positive QFT-Plus results. …”
Get full text

Ipatasertib combined with non-taxane chemotherapy for patients with previously treated advanced triple-negative breast cancer: the PATHFINDER phase IIa trial by Elena López-Miranda, Jose Manuel Pérez-García, María Gión, Nuria Ribelles, Patricia Cortez-Castedo, José Luis Alonso-Romero, María Martínez García, Santiago González-Santiago, Begoña Bermejo, Serafín Morales, Vicente Carañana, Laia Garrigós, Melissa Fernández-Pinto, Silvia García-Vicente, Alicia Garcia-Sanz, Arnau Mena-Molina, Olga Boix, Daniel Alcalá-López, Antonio Llombart-Cussac, Javier Cortés

Subjects: Get full text

Ensemble learning methods with single and multi-model deep learning approaches for cephalometric landmark annotation by S. Rashmi, S. Srinath, R. Rakshitha, B. V. Poornima

“…Additionally, the efficacy of these approaches is examined by implementing two distinct deep architectures, namely UNet and UNetPlusPlus. The combination of the single model and multi-model approach with UNet and UNetPlusPlus results in four base learners, each displaying varying accuracy for different landmarks. …”
Get full text

Re-exposition to ipilimumab plus nivolumab in metastatic Merkel cell carcinoma by Valerie Glutsch, Patrick Schummer, Matthias Goebeler, Anja Gesierich, Bastian Schilling, Bastian Schilling

“…However, all three patients progressed during follow-up and were re-exposed to IPI/NIVO. …”
Get full text

Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment by Eugen Feist, Roy M. Fleischmann, Saeed Fatenejad, Daria Bukhanova, Sergey Grishin, Sofia Kuzkina, Michael Luggen, Evgeniy Nasonov, Mikhail Samsonov, Josef S. Smolen

Get full text

Non-pharmacotherapeutic atmiatrics with combined mud medication «Tone plus» in pulmonology by T. N. Zaripova, I. N. Smirnova, V. S. Moskvin, I. I. Antipova

“…Inhalations with «Tone plus» consisting of three components — saline carrier, herb and peloids extracts — have been the main medication. …”
Get full text

Daratumumab plus carfilzomib: An optimistic approach in relapsed/refractory multiple myeloma by A P Dubey, Sameer Khatri, Sachin Maggo, Nilabh K Singh, Durgesh Sharma

“…Patients who have been heavily treated for relapsed/refractory MM (RRMM) have limited options and poor survival outcomes. Carfilzomib plus daratumumab combination have been evaluated in a phase 1b study in patients of RRMM progressing after 1–3 lines of therapies including bortezomib and an immune-modulatory drug. …”
Get full text

Gene expression analysis in circulating tumour cells to determine resistance to CDK4/6 inhibitors plus endocrine therapy in HR + /HER2- metastatic breast cancer patients by Miriam González-Conde, Celso Yáñez, Carmen Abuín, Corinna Keup, Ramón Lago-Lestón, Maribel Aybar, Lucía Pedrouzo, Patricia Palacios, Teresa Curiel, Juan Cueva, Carmela Rodríguez, Marta Carmona, Alexandra Cortegoso, Tomás García-Caballero, Laura Muinelo-Romay, Sabine Kasimir-Bauer, Rafael López-López, Clotilde Costa

“…CTC transcriptional characterization revealed a gene expression signature (STAT3highPRKCBhighCDK6low) that accurately classified HR + /HER2- metastatic BC patients who responded to CDK4/6i plus ET, regardless of the CTC isolation method (AUC > 0.8). …”
Get full text

ALBI Grade Analyses of TACE Combined with Anti-Angiogenesis Therapies Plus PD-1 Inhibitors versus Anti-Angiogenesis Therapies Plus PD-1 Inhibitors in Advanced HCC by Hong X, Hu D, Zhou WJ, Wang XD, Huang LH, Huang TA, Guan YW, Qian J, Ding WB

“…Xin Hong,1,* Di Hu,2,* Wen-Jie Zhou,3,* Xiu-De Wang,4 Li-Hua Huang,5 Tian-An Huang,1 Yi-Wei Guan,1 Jingyu Qian,6 Wen-Bin Ding1 1Department of Interventional Radiology, Affiliated Hospital 2 of Nantong University, Nantong, People’s Republic of China; 2Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of China; 3Department of Interventional Radiology, Northern Jiangsu People’s Hospital, Clinical Medical College of Yangzhou University, Yangzhou, People’s Republic of China; 4Department of Interventional Radiology, Nantong Second People’s Hospital, Nantong, People’s Republic of China; 5Department of Interventional Radiology, Nantong Haimen District People’s Hospital, Nantong, People’s Republic of China; 6Department of Interventional Radiology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, People’s Republic of China*These authors contributed equally to this workCorrespondence: Wen-Bin Ding, Department of Interventional Radiology, Affiliated Hospital 2 of Nantong University, Nantong, 226001, People’s Republic of China, Tel/Fax +86 15951302169, Email 15951302169@163.com Jingyu Qian, Department of Interventional Radiology, the First Affiliated Hospital of Bengbu Medical University, Bengbu, 233004, People’s Republic of China, Tel/Fax +86 13004081388, Email jyqian1388@163.comObjective: To evaluate the baseline albumin-bilirubin (ALBI) grade’s role in advanced hepatocellular carcinoma (HCC) receiving transarterial chemoembolization (TACE) plus anti-angiogenesis therapies and PD-1 inhibitors (TACE+TP) versus anti-angiogenesis therapies and PD-1 inhibitors (TP).Methods: This multicenter retrospective study enrolled advanced HCC undergoing TACE+TP or TP from January 2019 to June 2023 at three hospitals in China. …”
Get full text

Real world effectiveness of chemotherapy plus bevacizumab with immunotherapy in colorectal cancer by Zhao Gao, Xiaoyan Wang, Tao Song, Shikai Wu, Xuan Jin

Get full text

Influence of a new combination anthelmintic aversect plus on dog’s organism by K. G. Kurochkina, Z. G. Musaev

“…It’s determinate that a new combination anthelmintic aversect plus at dose levels 0,5 mg/kg and 5 mg/kg of body weight according to aversect-3 and praziquantel, don’t show negative effects on blood and no specific resistance of dogs.…”
Get full text

Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab by Narek Shaverdian, Maria Thor, Annemarie F. Shepherd, Michael D. Offin, Andrew Jackson, Abraham J. Wu, Daphna Y. Gelblum, Ellen D. Yorke, Charles B. Simone II, Jamie E. Chaft, Matthew D. Hellmann, Daniel R. Gomez, Andreas Rimner, Joseph O. Deasy

Get full text

Promising Response to Neoadjuvant Chemotherapy Plus Immunotherapy in Metaplastic Breast Carcinoma by Tan Q, Li N, Wang Y, Du T, Liang G, Zhao Z, Tang J, Wu H

Get full text

Aumolertinib plus bevacizumab for untreated advanced NSCLC with EGFR sensitive mutation by Lingping Kong, Lina Peng, Xue Yang, Qing Ma, Linlin Zhang, Xia Liu, Diansheng Zhong, Fanlu Meng

“…The progression-free survival (PFS) improvement of the combination of first-generation EGFR-TKIs and bevacizumab was confirmed by CTONG1509, JO25567, and NEJ026 studies, however, the effect of third-generation EGFR-TKIs plus bevacizumab remains under debate. This study aimed to investigate the efficacy and safety of aumolertinib plus bevacizumab in untreated EGFRm advanced NSCLC.MethodsWe conducted a phase II single-arm prospective clinical trial for advanced EGFRm NSCLC treated with aumolertinib combined with bevacizumab. …”
Get full text

Recomposition des collectifs agricoles pour des filières plus durables by Hichem Amichi, Julien Frayssignes, Marie-Christine Henninger, Arnaud Buchs

Get full text

Effect of Shenqi Dihuang Decoction plus benazepril on diabetic kidney disease by Chan-juan Nie, Yong-hua Song, Jie-nan Zhang, Na Xu

Get full text

An Alternating Direction Method for Mixed Gaussian Plus Impulse Noise Removal by Si Wang, Ting-Zhu Huang, Xi-le Zhao, Jun Liu

Get full text

MAX-PLUS ALGEBRA MODEL ON INAPORTNET SYSTEM SHIPS SERVICE SCHEME by Nurwan Nurwan, Muhammad Rezky F. Payu

Get full text

Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients by Paul J. Hengeveld, Joyce Schilperoord-Vermeulen, P. Martijn Kolijn, Julie M. N. Dubois, Peter E. Westerweel, Sabina Kersting, Arnon P. Kater, Mark-David Levin, Anton W. Langerak

Get full text

MASALAH EIGEN DAN EIGENMODE MATRIKS ATAS ALJABAR MIN-PLUS by Eka Widia Rahayu, Siswanto Siswanto, Santoso Budi Wiyono

Get full text